Treatment decisions in metastatic colorectal cancer – Beyond first and second line combination therapies
Arndt Vogel(Princess Margaret Cancer Centre), Dirk Arnold(Asklepios Klinik Altona), Stefan Kubicka(Medizinische Hochschule Hannover), Ralf‐Dieter Hofheinz(University of Mannheim)
Cited by 144
Related Papers
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k